New registered manufacturer is publicly announced

in page functions

With the June launch of the pilot AMC against pneumococcal disease, manufacturers are now registering to participate

Geneva, 30 September 2009 - Panacea Biotect Ltd and the Serum institute of India are two of the companies that have begun the registration process in order to participate. Several companies have inquired about the pilot.

Information about the number and names of manufacturers is confidential unless a firm requests its information to be made public.

For more information about the AMC registration process please contact: amc@gavi.org 

65 million

In 2017 alone, 65 million children were immunised with Gavi-supported vaccines. This equates to more than 190 million points of contact between these children and the primary health system and provides a robust platform for other health interventions.

WHO/UNICEF 2018

More facts...

close icon

modal window here